Brain-machine interfaces (BMI) or brain-computer interfaces (BCI) have been used in medical applications for several years – primarily in cochlear implants to provide profoundly deaf people with a sense of sound. They are now being applied to other areas as well. A brain-machine interface is a device that translates brain signals into commands capable of controlling external software or hardware. These interfaces can also translate external commands into neuronal information.
Brain-machine interfaces have applications in various fields such as medical, communication and control, smart home control, and entertainment and gaming. BMI technology provides physically-challenged individuals with movement and communication skills. It enables those afflicted with Parkinson’s, epilepsy, paralysis and Alzheimer’s to carry out activities independently – such as operating wheelchairs, prosthetics and various other instruments. Commands imparted to the brain through a BMI can give a sense of sound to a deaf person. They can also enhance the mood of a person suffering from anxiety or depression.
The global brain-computer interface market size was valued at USD 806.8 million in 2015 and is expected to reach USD 1.72 billion in 2022, growing at a CAGR of 11.50% during the forecast period. Provided in this report are insights into the patents addressing the technologies and applications related to brain-machine interfaces.
